Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

1.

Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.

Ishigooka J, Inada T, Miura S.

Psychiatry Clin Neurosci. 2001 Aug;55(4):403-14.

PMID:
11442893
[PubMed - indexed for MEDLINE]
2.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group.

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
[PubMed - indexed for MEDLINE]
3.

Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.

Tran PV, Dellva MA, Tollefson GD, Beasley CM Jr, Potvin JH, Kiesler GM.

J Clin Psychiatry. 1997 May;58(5):205-11. Erratum in: J Clin Psychiatry 1997 Jun;58(6):275.

PMID:
9184614
[PubMed - indexed for MEDLINE]
4.

A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.

Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, Breier A.

Clin Ther. 2003 May;25(5):1420-8.

PMID:
12867218
[PubMed - indexed for MEDLINE]
5.

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.

Tollefson GD, Beasley CM Jr, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME.

Am J Psychiatry. 1997 Apr;154(4):457-65.

PMID:
9090331
[PubMed - indexed for MEDLINE]
6.

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.

Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V; Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine.

JAMA. 2003 Nov 26;290(20):2693-702.

PMID:
14645311
[PubMed - indexed for MEDLINE]
7.

Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia.

Breier A, Hamilton SH.

Biol Psychiatry. 1999 Feb 15;45(4):403-11.

PMID:
10071708
[PubMed - indexed for MEDLINE]
8.

Olanzapine versus haloperidol treatment in first-episode psychosis.

Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C Jr, Tollefson GD.

Am J Psychiatry. 1999 Jan;156(1):79-87.

PMID:
9892301
[PubMed - indexed for MEDLINE]
9.

Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.

Gomez JC, Crawford AM.

J Clin Psychiatry. 2001;62 Suppl 2:6-11.

PMID:
11232753
[PubMed - indexed for MEDLINE]
10.

Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol.

Inada T, Yagi G, Miura S.

Schizophr Res. 2002 Oct 1;57(2-3):227-38.

PMID:
12223254
[PubMed - indexed for MEDLINE]
11.

Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.

Tollefson GD, Sanger TM, Lu Y, Thieme ME.

Arch Gen Psychiatry. 1998 Mar;55(3):250-8. Erratum in: Arch Gen Psychiatry 1998 Nov;55(11):1052.

PMID:
9510219
[PubMed - indexed for MEDLINE]
12.

Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.

Conley RR, Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, Hegerty J, Love R, Gounaris C, Zaremba S.

Am J Psychiatry. 1998 Jul;155(7):914-20.

PMID:
9659857
[PubMed - indexed for MEDLINE]
13.

Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.

Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PL, Breier A.

Can J Psychiatry. 2003 Dec;48(11):716-21.

PMID:
14733451
[PubMed - indexed for MEDLINE]
14.

An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.

Carlson CD, Cavazzoni PA, Berg PH, Wei H, Beasley CM, Kane JM.

J Clin Psychiatry. 2003 Aug;64(8):898-906.

PMID:
12927004
[PubMed - indexed for MEDLINE]
15.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
16.

Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.

Revicki DA, Genduso LA, Hamilton SH, Ganoczy D, Beasley CM Jr.

Qual Life Res. 1999 Aug;8(5):417-26.

PMID:
10474283
[PubMed - indexed for MEDLINE]
17.

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.

Beasley CM Jr, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S.

Neuropsychopharmacology. 1996 Feb;14(2):111-23.

PMID:
8822534
[PubMed - indexed for MEDLINE]
Free Article
18.

Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2002 Feb;159(2):255-62. Erratum in: Am J Psychiatry 2002 Dec;159(12):2132.

PMID:
11823268
[PubMed - indexed for MEDLINE]
19.

Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial.

Kennedy JS, Jeste D, Kaiser CJ, Golshan S, Maguire GA, Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore JA, Breier A.

Int J Geriatr Psychiatry. 2003 Nov;18(11):1013-20.

PMID:
14618553
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk